Clinical Trial Update: ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT [Phase 2]

View source ↗

Summary

Phase 2 trial update on ARTA-based chemo-free bridging and maintenance therapy accompanying CAR-T treatment for high-risk relapsed/refractory B-cell non-Hodgkin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: B-cell Non Hodgkin Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING